Vaxi-DL: The Deep Learning Pipeline for Vaccine Precision

Our robust deep learning architecture optimizes antigen selection and sequence design for maximum immunogenicity and efficacy.

See the Pipeline

How Deep Learning Transforms Vaccine Design

Accelerated Target Identification

Vaxi-DL processes vast datasets of viral, bacterial, and cancer genomic information, identifying potential epitopes far faster than traditional methods. Our models are trained on millions of known immune interactions.

This allows us to rapidly filter out ineffective candidates, focusing resources only on those with the highest probability of inducing a strong T-cell response.

High Throughput Sequencing Visualization

Predictive Immunogenicity Scoring

Our proprietary deep neural networks predict a comprehensive immunogenicity score based on MHC binding affinity, T-cell receptor recognition probability, and antigen processing likelihood.

This multi-factor prediction ensures the designed vaccine is not just a theoretical match but a highly functional one in a real biological context.

Neural Network on DNA strand visualization

Key Advantages of Vaxi-DL

Speed

Reduce target validation time from months to weeks.

Scalability

Process massive omics data efficiently for global research efforts.

Accuracy

Achieve industry-leading prediction rates for T-cell epitopes.